Trials / Completed
CompletedNCT03109327
Investigating the Clinical Utility of the MDS
Investigating the Clinical Utility of the MDS Test for the Oncogenic Activity in Nevi Suspected of Being Melanoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (actual)
- Sponsor
- Orlucent, Inc · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to establish the clinical utility of the Melanoma Detection System (MDS).
Detailed description
The purpose of this study is to establish the clinical utility of the MDS while continuing to evaluate the safety and performance of the MDS in patients with skin lesions who are referred to secondary care clinics for evaluation, whose lesions (moles) are suspicious for melanoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Melanoma Detection System -MDS | Imaging of lesion using the MDS test. |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2020-10-30
- Completion
- 2020-10-30
- First posted
- 2017-04-12
- Last updated
- 2020-11-19
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03109327. Inclusion in this directory is not an endorsement.